FOXO4-DRI
FOXO4-DRI 10 mg is a D-retro-inverso peptide that blocks the FOXO4-p53 interaction, used in cellular-senescence research.
Defined for research.
FOXO4-DRI 10 mg is a D-retro-inverso peptide that blocks the FOXO4-p53 interaction, used in cellular-senescence research.
Specifications
| Product | FOXO4-DRI |
|---|---|
| Unit size | 10mg per vial |
| Form | Lyophilised powder |
| Intended use | Laboratory research |
Description
About FOXO4-DRI
FOXO4-DRI is a 46-amino-acid D-retro-inverso peptide derived from the p53-binding region of the FOXO4 transcription factor. Built from D-amino acids in reversed order, this cell-permeable peptide resists protease breakdown and is used in research to disrupt the FOXO4-p53 interaction in senescent cells.
Key features of FOXO4-DRI
- D-retro-inverso peptide (46-amino-acid)
- Sequence: D-(Leu-Thr-Leu-Arg-Lys-Glu-Pro-Ala-Ser-Glu-Ile-Ala-Gln-Ser-Ile-Leu-Glu-Ala-Tyr-Ser-Gln-Asn-Gly-Trp-Ala-Asn-Arg-Arg-Ser-Gly-Gly-Lys-Arg-Pro-Pro-Pro-Arg-Arg-Arg-Gln-Arg-Arg-Lys-Lys-Arg-Gly) (46 amino acids)
- Lyophilised solid — stable, easy to store, straightforward to reconstitute
- Unit size: 10 mg / vial
- Every batch released only after identity, purity, and appearance QC
- Certificate of Analysis (CoA) and batch documentation available on request
FOXO4-DRI technical specifications
| Product name | FOXO4-DRI |
| Synonyms | Proxofim; FOXO4 D-retro-inverso peptide; FOXO4 DRI |
| Amino-acid sequence | D-(Leu-Thr-Leu-Arg-Lys-Glu-Pro-Ala-Ser-Glu-Ile-Ala-Gln-Ser-Ile-Leu-Glu-Ala-Tyr-Ser-Gln-Asn-Gly-Trp-Ala-Asn-Arg-Arg-Ser-Gly-Gly-Lys-Arg-Pro-Pro-Pro-Arg-Arg-Arg-Gln-Arg-Arg-Lys-Lys-Arg-Gly) |
| Class | D-retro-inverso peptide (46-amino-acid) |
| Molecular formula | C₂₂₈H₃₈₈N₈₆O₆₄ |
| Molecular weight | ~5,358 g/mol |
| CAS number | 2460055-10-9 |
| Purity | ≥99% (HPLC) |
| Physical form | Lyophilised powder |
| Appearance | White to off-white solid |
| Unit size | 10 mg / vial |
| Note | All residues are D-amino acids |
Reconstituting and storing FOXO4-DRI
- Before reconstitution: Store lyophilised vials at 2–8 °C, protected from light and moisture.
- Equilibrate: Allow vial and diluent to reach room temperature before opening.
- Reconstitute: Add Mixing Water (2 ml recommended). Swirl gently — do not vortex.
- After reconstitution: Store at 2–8 °C. Prepare aliquots to minimise freeze–thaw cycles.
- Compatibility: Use only within protocols that comply with your institution’s SOPs and local regulations.
Looking for complementary materials? See Epitalon 10mg — telomere research peptide, MOTS-c 10mg, Mixing Water 10 ml.
FOXO4-DRI in research
FOXO4-DRI is studied in cellular-senescence research, where blocking FOXO4-p53 binding releases p53 from the nucleus and triggers apoptosis selectively in senescent cells. Laboratories use it in senolytic models, ageing-biology studies and protein-protein interaction work. Preclinical findings do not establish safety or efficacy in humans.
Synthesis and quality assurance
Avanti Peptides manufactures FOXO4-DRI via controlled, validated solid-phase peptide synthesis (SPPS) to deliver high purity and lot-to-lot consistency. Each batch undergoes identity verification, HPLC purity analysis (≥99%), and appearance inspection before release.
Frequently asked questions about FOXO4-DRI
What is FOXO4-DRI?
How should I store the peptide?
What diluent should I use for reconstitution?
Do you provide batch documentation / Certificate of Analysis?
Is this product intended for human use?
Legal & safety notice
External resources for researchers
| Product | FOXO4-DRI |
|---|---|
| Unit size | 10mg per vial |
| Form | Lyophilised powder |
| Intended use | Laboratory research |
Third-party report for this size is pending publication. Contact us for batch details.
Know your batch.
Match your vial's lot number to its documentation.





